Model
Edge
4D Molecular Therapeutics
0001881504
Filing Type
4
Filing Date
12/12/2023
Updated
12/13/23, 9:05 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership